U.S. Anticoagulant Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service analyzes the changing dynamics in the U.S. anticoagulant market for the period 2002-2012. Included are pipeline analysis, and individual segment revenue forecasts as well as selected major products. Both products currently in the market, as well as those forecast to enter the market by 2012 are included, with an emphasis on branded drug products. The market is segmented by product class: warfarin, heparins, direct thrombin inhibitors, synthetic pentasaccharides, and emerging anticoagulant products. The products covered in this research service are used in the treatment of diseases such as acute coronary syndromes, venous thromboembolism, stroke, and atrial fibrillation.

Table of Contents

U.S. Anticoagulant Market, Executive SummaryExecutive SummaryIntroductionU.S. Anticoagulant Market, Total MarketResearch Scope and MethodologyScope and SegmentationResearch MethodologyOverviewIntroductionDisease OverviewCoagulation Pathways and TestingSelected ProceduresMarket Engineering MeasurementsGeneral Market TrendsIndustry Issues and ChallengesMarket DriversMarket RestraintsTotal Market ForecastsRevenue ForecastsMarket Share AnalysisCompetitive StructureOverviewFrost & Sullivan AwardsCompany of the Year AwardProduct Differentiation Innovation of the Year AwardIndustry Innovation and Advancement of the Year AwardBrand Development Strategy Leadership of the Year AwardU.S. Anticoagulant Market, Warfarin MarketOverviewIntroductionMarket Engineering MeasurementsProduct Analysis - WarfarinPipeline AnalysisMarket ForecastsRevenue ForecastsMarket Share AnalysisU.S. Anticoagulant Market, Heparins MarketOverviewIntroductionMarket Engineering MeasurementsProduct Analysis - HeparinsPipeline AnalysisMarket ForecastsRevenue ForecastsMarket Share AnalysisU.S. Anticoagulant Market, Direct Thrombin Inhibitors MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsRevenue ForecastsMarket Share AnalysisU.S. Anticoagulant Market, Synthetic Pentasaccharides MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsRevenue ForecastsU.S. Anticoagulant Market, Emerging Anticoagulant MarketOverviewIntroductionPipeline AnalysisMarket ForecastsRevenue ForecastsU.S. Anticoagulant Market, AppendixDecision Support DatabasesIncidence of StrokeIncidence of Myocardial InfarctionCirculatory Disease MortalityHeart Attack MortalityTotal Population




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.